Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis. Aytekin F, Efe O, Beyhan N, Gidik E, et al. Allergy Asthma Proc 2025;46:280-286.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aytekin F, Efe O, Beyhan N, Gidik E, et al. Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 2025;46:280-286.
PMID: 40624778